Kirsten Grüneberg

DR. KIRSTEN GRÜNEBERG

Co-Founder and Managing Principal
Grüneberg Global IP

Dr. Kirsten A. Grüneberg is Co-Founder and Managing Principal of Grüneberg Global IP, an international intellectual property firm advising many of the world’s largest corporations on complex, high-value patent strategy and global portfolio architecture.

She leads the firm’s strategic direction and oversees the design, defense, and coordination of large-scale patent portfolios across the United States, Europe, and Asia, serving U.S. Fortune 50, Global Fortune 200, DAX-listed, and Nikkei 225 companies in the chemical, biotechnology, pharmaceutical, semiconductor, and advanced technology sectors.

Her work focuses on institutional portfolio stewardship, post-grant strategy, Hatch-Waxman and regulatory alignment, and cross-border IP considerations in high-value commercial transactions. She has successfully defended major pharmaceutical patents in post-grant proceedings, contributing to business outcomes involving transactions valued in the hundreds of millions of dollars.

Under her leadership, the firm has deliberately integrated advanced AI-supported analytical systems into drafting, portfolio analytics, and operational workflows. These systems operate within a senior-led structure designed to enhance precision, scalability, and institutional consistency while preserving experienced legal judgment at every critical stage.

Practice Focus

Dr. Grüneberg advises multinational enterprises on:

• Global patent portfolio architecture and prosecution strategy

• Post-grant proceedings, including inter partes review and reexamination

• Hatch-Waxman strategy, patent term extension, and Orange Book matters

• IP considerations in cross-border mergers and acquisitions

• Regulatory alignment and product clearance strategy

Her approach emphasizes long-term portfolio durability, coordinated global execution, and strategic alignment with enterprise-level business objectives.

Technical and Scientific Background

Dr. Güneberg’s technical expertise spans polymers, specialty chemicals, automotive additives, coatings, advanced materials, semiconductors, battery technologies, nanotechnology, small-molecule and biologic pharmaceuticals, medical devices, diagnostics, drug delivery systems, and Industry 4.0 technologies.

After receiving her Ph.D. in organic chemistry, magna cum laude, from the Technische Universität Berlin, she was awarded a Lynen Fellowship from the Alexander von Humboldt Foundation to conduct research at the U.S. Naval Research Laboratory. She subsequently served as a visiting professor at Georgetown University Medical Center and held research positions at the U.S. Naval Research Laboratory and the Max Planck Institute of Colloids and Interfaces.

Dr. Grüneberg has authored more than 50 scientific publications and conference presentations and is an inventor on multiple U.S. and international patents. She is a native German speaker and regularly works with clients across Europe and Asia on complex cross-border matters.